Profile
Colin Conrad Collins was the founder of Hexamer Therapeutics, Inc. and held the title of Chief Scientific Officer & Director.
Colin Conrad Collins active positions
| Companies | Position | Start |
|---|---|---|
Hexamer Therapeutics, Inc.
 Hexamer Therapeutics, Inc. BiotechnologyHealth Technology Hexamer Therapeutics, Inc. engages in the provision of vaccine platform. Its projects include SARS-CoV-2 vaccines and neoantigen based cancer therapy. The company was founded by Robert Hale Bogden, Keith David Miller, and Colin Conrad Collins and is headquartered in Pullman, WA. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Hexamer Therapeutics, Inc.
Hexamer Therapeutics, Inc. BiotechnologyHealth Technology Hexamer Therapeutics, Inc. engages in the provision of vaccine platform. Its projects include SARS-CoV-2 vaccines and neoantigen based cancer therapy. The company was founded by Robert Hale Bogden, Keith David Miller, and Colin Conrad Collins and is headquartered in Pullman, WA. | Health Technology |
- Stock Market
- Insiders
- Colin Conrad Collins
